Growth Hormone or Sildenafil as Therapies for Fatigue in MTBI
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Sildenafil (Primary) ; Somatropin (Primary)
- Indications Brain injuries; Somatotropin deficiency
- Focus Therapeutic Use
- 26 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 19 Jun 2015 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017 as per ClinicalTrials.gov record.